Subcategory
Other indications (e.g. myeloproliferative diseases)
Trial Type
First-Line-Therapy (Metastatic Disease/Hematology)
Description for experts
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft Versus-Host Disease
Description for laymen
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft Versus-Host Disease
JSON Data
{
"short_title": "INCA34176-357",
"data_mode": "910",
"data_mode_number": "000000062",
"official_title": null,
"accrual_state": "running",
"therapeutic_value": "not_applicable",
"therapieansatz_value": "not_applicable",
"therapieintervention_value": "not_applicable",
"therapielinie_value": "first",
"ctgov_number": null,
"eudract_number": "2023-510292-65-00",
"general_contact_email": "sal-aml-register@ukdd.de",
"general_contact_phone": "+49 351-45818380",
"hauptpruefer_dd_name": null,
"description_laie_de": "Eine randomisierte, doppelblinde, placebokontrollierte Phase-III-Studie mit Axatilimab und Kortikosteroiden als Erstbehandlung der \r\nchronischen Graft-versus-Host-Krankheit",
"description_laie_en": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft Versus-Host Disease",
"description_expert_de": "Eine randomisierte, doppelblinde, placebokontrollierte Phase-III-Studie mit Axatilimab und Kortikosteroiden als Erstbehandlung der \r\nchronischen Graft-versus-Host-Krankheit",
"description_expert_en": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft Versus-Host Disease",
"rechtsgrundlage_value": null,
"phase_amg_value": null,
"main_cat_id": 4,
"sub_cat_id": 22
}
